Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizoaffective and Schizophreniform Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT04203056
What this trial is testing

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

Who this might be right for
SchizophreniaSchizoaffective Disorder, Depressive TypeSchizophreniform Disorder
University of California, Los Angeles 15
Post-approval studies (Phase 4)Study completedNCT00595504
What this trial is testing

Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Massachusetts General Hospital 25
Post-approval studies (Phase 4)Study completedNCT00320671
What this trial is testing

Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis

Who this might be right for
Schizophrenia
Northwell Health 198
Not applicableEnded earlyNCT00515489
What this trial is testing

Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Janssen-Cilag, S.A. 1,882
Post-approval studies (Phase 4)Study completedNCT00361543
What this trial is testing

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
The Alfred 54
Post-approval studies (Phase 4)Study completedNCT00044187
What this trial is testing

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Who this might be right for
SchizophreniaPsychotic DisordersBipolar Disorder
Eli Lilly and Company 130
Large-scale testing (Phase 3)Study completedNCT00159770
What this trial is testing

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychotic Disorders
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 290
Post-approval studies (Phase 4)Ended earlyNCT02949232
What this trial is testing

Prednisolone Addition for Patients With Recent-onset Psychotic Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
UMC Utrecht 42
Not applicableLooking for participantsNCT07645443
What this trial is testing

FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis

Who this might be right for
Delusional DisorderBrief Psychotic DisorderSchizophreniform Disorder+2 more
Stephanie Mehl 252
Not applicableEnded earlyNCT00511628
What this trial is testing

Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Janssen-Cilag, S.A. 1,717
Large-scale testing (Phase 3)Study completedNCT05658510
What this trial is testing

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

Who this might be right for
Agitation,PsychomotorBipolar I DisorderBipolar II Disorder+3 more
BioXcel Therapeutics Inc 452
Not applicableStudy completedNCT00349973
What this trial is testing

Clinical Trial of Dipyridamole in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
University of Maryland, Baltimore 29
Testing effectiveness (Phase 2)Study completedNCT00206570
What this trial is testing

Clinical Estradiol Trial in Women With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Bayside Health 100
Large-scale testing (Phase 3)Study completedNCT00419146
What this trial is testing

Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder+1 more
University Hospital, Aker 99
Not applicableStudy completedNCT00749970
What this trial is testing

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
AstraZeneca 100
Not applicableLooking for participantsNCT05890183
What this trial is testing

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode

Who this might be right for
SchizophreniaSchizophreniform DisorderSchizoaffective Disorder
University of California, Los Angeles 100
Not applicableUnknownNCT00789022
What this trial is testing

Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment

Who this might be right for
SchizophreniaSchizophreniformSchizoaffective Disorder+1 more
Shalvata Mental Health Center 80
Post-approval studies (Phase 4)UnknownNCT00465283
What this trial is testing

Donepezil Double Blind Trial for ECT Memory Disfunction

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
BeerYaakov Mental Health Center 40
Testing effectiveness (Phase 2)Study completedNCT07116694
What this trial is testing

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder

Who this might be right for
Bipolar I DisorderBipolar II DisorderSchizophrenia+3 more
BioXcel Therapeutics Inc 33
Post-approval studies (Phase 4)Study completedNCT01855074
What this trial is testing

An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders

Who this might be right for
SchizophreniaSchizophreniform DisorderSchizoaffective Disorder
Janssen-Cilag Ltd. 80
Next Page